Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2018

Aug 16, 2018

3091_iss_2018-08-16_4ae75c7c-8c08-4cfa-addf-9e8f1d457b53.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary shares
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 16/08/2018
Limit for number of shares 25 %
Limit for number of votes 25 %
After the transaction
Quantity
Shares 10,420,805
Directly held voting rights 10,420,805
Indirectly held voting rights 0
Percentage
Directly held shares 23.67341 %
Directly held voting rights 23.67341 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 23.67341 % 10,420,805
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 23.67341 % 10,420,805
Group total holdings
Voting rights
10,420,805
Percentage of voting rights 23.67341
Published
16/08/2018 16:27
Contact
Name
Jonas Jendi
Phone
0738000848 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25